BioPharma Services Inc. is FDA-inspected, UK MHRA-inspected, and Health Canada-inspected Canadian Contract Research Organization.
BioPharma Services Inc. is a physician-owned, physician-run, FDA-inspected, UK MHRA-inspected, and Health Canada-inspected Canadian Contract Research Organization (CRO) which specializes in the conduct of Bioequivalence (BE) Studies and Phase I/IIa clinical trials and bioanalysis for innovative pharmaceutical, biotech and medical device companies and for submission to the US, Canada, Australia and Europe.
Its service offerings include Clinical Trial Research (Phase I/IIa), Bioequivalence Studies, Pharmacokinetic Analysis, Regulatory Affairs, Data Management, Quality Assurance, Project Management, and Statistical Services. The company was founded in 2006, and it has grown to serve over 30 pharmaceutical and medical device companies globally.
Bio Pharma Services Inc. has a state-of-the-art 50,000 square-feet, 174-bed clinical facility based in Toronto, Canada, which has successfully passed inspections by the US FDA, Health Canada, UK MHRA, and numerous customers.
To be a client-focused partner, where people matter, providing excellence in Early-Stage Clinical Research to the global pharmaceutical community.
"Innovative End-to-End Solutions for Phase 1 Clinical TrialsClinical trial complexity has strikingly escalated during the last decades, including a surge in the number of performed procedures, associated costs, and administrative load. Phase 1 clinical trials pose an especially significant challenge due to the requirements for extensive safety monitoring and correlative testing and the high failure rate of developmental drug candidates. BioPharma Services Inc. offers end-to-end solutions for Phase 1 clinical trials ranging from clinical trial design and execution to data reporting and tabulation and the preparation of a final Clinical Study Report. In addition, we have niche expertise in a number of study areas."to add BioPharma Services Inc map to your website;
